| NCT02587572 | Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial | WITHDRAWN | PHASE2 | 2023-12-01 | 2023-12 | 2023-12 |
| NCT05233774 | Lomecel-B Effects on Alzheimer's Disease | COMPLETED | PHASE2 | 2021-12-28 | 2023-09-29 | 2023-09-29 |
| NCT04925024 | Evaluation of Lomecel-Bâ„¢ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. | ACTIVE_NOT_RECRUITING | PHASE2 | 2021-06-25 | 2026-08-31 | 2026-06-30 |
| NCT04629105 | Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER) | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-07-24 | 2025-07 | 2024-06 |
| NCT03525418 | Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2018-02-21 | 2025-12-31 | 2024-06-30 |
| NCT03169231 | Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty | COMPLETED | PHASE2 | 2017-07-06 | 2021-09-30 | 2021-09-30 |
| NCT02982915 | Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty | COMPLETED | PHASE1, PHASE2 | 2016-11 | 2022-09 | 2021-09 |
| NCT02600130 | Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease | COMPLETED | PHASE1 | 2016-10-10 | 2021-09 | 2020-09 |
| NCT02398604 | Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome | TERMINATED | PHASE1 | 2015-04 | 2019-03 | 2019-03 |
| NCT02065245 | AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery | COMPLETED | PHASE1, PHASE2 | 2014-03-03 | 2020-10-02 | 2019-10-02 |